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Phenolic compounds are ubiquitous in plant-based foods. High dietary intake of fruits, 
vegetables and cereals is related to a decreased rate in chronic diseases. Phenolic compounds 
are thought to be responsible, at least in part, for those health effects. Nonetheless, phenolic 
compounds bioaccessibility and biotransformation is often not considered in these studies; 
thus, a precise mechanism of action of phenolic compounds is not known. In this review we aim 
to present a comprehensive knowledge of the metabolic processes through which phenolic 
compounds go after intake.
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Los compuestos fenólicos son ubicuos en alimentos de origen vegetal. La alta ingesta de frutas, 
vegetales y cereales está relacionada con un bajo índice en padecimientos crónicos. Se cree que 
los compuestos fenólicos son, en parte, responsables de este efecto benéfico. Sin embargo, 
la bioaccesibilidad y biotransformación de los compuestos fenólicos generalmente no es 
considerada en este tipo de estudios. Por lo tanto, no se ha podido obtener un mecanismo de 
acción de los compuestos fenólicos. En este trabajo, presentamos una revisión de literatura de 
los procesos metabólicos a través de los cuales los compuestos fenólicos son sometidos después 
de ser ingeridos.
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INTRODUCTION
Phenolic compounds constitute a large and an important 
group of phenylpropanoids produced by plants as secondary 
metabolites. Phenolic compounds have an aromatic ring and 
several hydroxyl groups attached to it. Phenolic compounds 
can be classified into different groups. They are grouped as 
a function of the number of phenolic rings that they contain 
and the radicals that bind these rings to another one1,2.
Phenolic compounds have received considerable attention 
because their dietary intake is related to lower incidence 
of chronic diseases, such as cancer, diabetes, Alzheimer’s 
disease and cardiovascular diseases. Cereals, fruits, and 
vegetables are rich sources of phenolic compounds. In fact, 
the health benefits of their dietary intake have been related, 
at least in part, to their phenolic compounds content3.
 
In nutrition science, bioavailability is defined as the fraction 
of an ingested nutrient or compound that reaches the 
FACTORS AFFECTING THE 
BIOAVAILABILITY OF DIETARY 
PHENOLIC COMPOUNDS
systemic circulation and the specific sites where it can 
exert its biological action. Bioavailability depends on proper 
absorption, release of a dosage form and presystemic 
elimination. Therefore bioavailability also depends on the 
route of administration and dosage form used, but can vary 
from one individual to another4,5.
Bioavailability is related to other two concepts bioaccessibility 
and bioactivity. In this sense, bioaccessibility is described as 
the amount of any food constituent that is released from 
the food matrix, detectable in the gut, and that may be 
able to pass through the intestinal barrier6. This is very 
important because only the compounds that are released 
from the food matrix or absorbed in the small intestine are 
potentially bioavailable and bioactive7.
Furthermore, it was recently proposed that once a 
compound is absorbed it is inevitably bioactive, therefore it 
was suggested that the concept of bioaccessibility includes 
bioactivity8. Nonetheless, it is important to note that the fact 
that a compound is bioaccessible does not always imply it is 
bioactive.
It is important to mention that bioavailability is influenced by 
phenolic structure, food processing and matrix, host, among 
others; besides all this factors can interact with each other 
and influence phenolic compounds bioavailability, which 
makes harder to define the exact mechanisms of action of 
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Most cereal phenols have covalent interactions with 
glycosides from the cell wall, forming ester linkages which 
are not hydrolysed by Phase I and II biotransformation 
enzymes, thus limiting their release into the colon to be 
metabolized by intestinal microbiota17,18. Such interactions 
depend on the specific porosity and surface properties 
of the cell wall that can measure between 4 and 10mm 
diameter which restricts the penetration of molecules with 
high molecular weight polyphenols (>10kDa)19. These bound 
phenols are also denominated conjugated. 
Free and some conjugated phenolic acids are thought 
to be readily available for absorption in the human small 
and large intestines12,20, however, those covalently bound 
to indigestible polysaccharides can only be absorbed after 
being released from cell structures by digestive enzymes or 
microorganisms in intestinal lumen20,21. The bound phenolic 
acids have very low bioavailability because the bran matrix 
severely hinders their access to the necessary enzymes 
(such as ferulate esterases, xylanases) that contribute to 
their release in the human gastrointestinal tract18,21,22.
In addition, during mastication of plant foods, cells are 
disrupted and polyphenols are released from cell; this can 
cause phytochemicals interact with components of dietary 
fibre as cellulose, hemicellulose and pectin, which affects 
bioavailability by increasing or decreasing it23–25.
Furthermore, some phenolic acids such as chlorogenic and 
caffeic acids, can form interactions with proteins, however, 
these interactions proved to be slightly disrupted during an 
in vitro digestion process and does not affect its bioavailability 
and absorption26.
BIOTRANSFORMATION OF DIETARY 
PHENOLIC COMPOUNDS
Biotransformation of xenobiotic compounds is the 
process of converting lipophilic chemicals into 
hydrophilic chemicals; thus, making the readily absorbed 
compounds into readily excreted compounds. Exceptions 
to this process are acetylation and methylation 
that can decrease the water solubility of certain 
xenobiotics. Phenolic compounds are categorised into 
xenobiotic compounds because humans do not produce 
them. Therefore, they undergo through xenobiotic 
biotransformation reactions27,28. 
Xenobiotic biotransformation reactions are divided 
phenolic compounds. Nonetheless, in this work we will focus 
on glycosylation and food matrix.
Glycosylation 
Phenolic compounds exist as free aglycones and glycoside 
forms. The last one can be as O-glycosides or as C-glycosides, 
with a number of sugars, glucose is the most commonly 
encountered, followed by galactose, rhamnose, xylose 
and arabinose, while mannose, fructose, glucuronic and 
galacturonic acids are unusual9,10.
Aglycones and polyphenols bound to glucose, galactose 
or xylose are absorbed in the small intestine after 
deglycosylation by β-glucosidase and lactase phlorizin 
hydrolase11, these enzymes releasing the aglycone within the 
intestinal lumen for absorption by a diffusion mechanism. 
Phenolic compounds bound to rhamnose must reach the 
colon to be hydrolyzed by bacterial ramnosidases prior to 
its absorption12. 
Flavonoids bound to sugars as β-glycosides are considered 
non-absorbable, only aglycones are able to pass through 
the gut wall. The major sites of flavonoid metabolism are the 
liver and the colonic flora. In the liver occurs O-methylation, 
sulfation and glucuronidation of hydroxyl groups improving 
flavonoid absorption; moreover, flavonoid glycosides are 
hydrolysed only by colon microorganisms, after this they 
can be absorbed13.
Most of in vivo studies show gastric absorption of aglycones 
as quercetin and daidzein, while glycosides are poorly 
absorbed12. However, Hollman and Katan observed that 
quercetin glycosides from onions were absorbed far well 
than the pure aglycone. Isoflavones aglycones are absorbed 
in the stomach, while their glycosides are absorbed in the 
intestine11. 
Within the glycosylated polyphenols, anthocyanins appear 
to be an exception, since the predominant forms in blood 
are their intact glycosides. Some authors have suggested 
the existence of a specific mechanism of anthocyanins 
absorption at the gastric level, which could involve transport 
via gastric bilitranslocase12,14,15.
Food matrix
The biological properties and bioavailability of some 
polyphenols depend largely on their release from the food 
matrix and their subsequent interaction with target tissues. 
Today, the food matrix is considered as the factor most 
decisive in the bioavailability and absorption of dietary 
polyphenols16. 
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and distributed to different tissues and organs. The 
fraction of phenol compounds not absorbed in the 
small intestine and that reaches the large intestine is 
metabolized by colonic bacteria. The action of colonic 
bacteria involves releasing aglycones and breakage 
of simple aromatic rings which may be absorbed after 
processing in benzoic acid derivatives and conjugation 
with glycine molecules, glucuronic acid or sulfate12,34.
Conjugation of hydroxycinnamic acids in vivo has 
implications for the bioactivity of these compounds, 
because the antioxidant capacity of hydroxycinnamic 
acids is given by the presence of free hydroxyl groups 
and these are the main sites of glucuronidation and 
sulfation35.
Phase I: Metabolism of Dietary Phenolic Compounds
Phase I biotransformation reactions are oxidation, 
reduction and hydrolysis. These reactions may increase, 
decrease or nullifying the biological activity of phenolic 
compounds27.
Reactions of phase I aim at changing the structure of 
the xenobiotic molecules. This modification is achieved 
by the introduction of hydroxyl functional groups, amino, 
carboxyl, among others. The purpose of this process 
is to increase the polarity of the xenobiotic phenolic 
compound for easy excretion27.
into four categories: 1) hydrolysis, 2) reduction, 3) 
oxidation and 4) conjugation. Nonetheless, oxidation and 
conjugation reactions are the most important in dietary 
phenol studies. These reactions can occur whether in 
the cytosol or cellular organelles such as microsomes 
or mitochondria, and the main tissues in which these 
processes occur are small intestine and liver27.
The structure of most dietary phenolic compounds 
reaching the peripheral circulation and tissues is 
different from the structure of those present in foods, 
this due to the metabolism to which they are subjected 
after intake11,29–31.
Some enzymes involved in these processes are phenol-
sulfotransferases, β-glucosidase, lactase phlorizin 
hydrolase and UDP-glucuronosyl transferases. The 
absorption and bioavailability of phenolic compounds 
depend largely on their metabolism in the small intestine. 
Moreover, only compounds that are not absorbed in the 
stomach and small intestine are degraded by the colonic 
microbiota29.
Nevertheless, during mastication and gastric digestion, 
the structure and interactions of phenolic compounds 
with food matrix may be modified. This can diminish or 
improve their bioaccessibility in the small intestine29,32.
The resultant metabolites of these conjugation reactions 
are transported through blood bound mainly to albumin 
Figure 1. Schematic simplified representation of the metabolic pathway of plant phenols in humans after ingestion. 
Adapted from Vacek et al.33
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Hydrolysis: Hydrolytic reactions mainly target functional 
groups as carboxylic acid ester, amide, lactone 
and others. Some of the major hydrolytic enzymes 
in mammals are carboxylesterases. Nevertheless, 
aldehyde dehydrogenases, carbonic anhydrases, 
carboxypeptidases, lipases and proteases have shown to 
have hydrolytic activity27.  
The enzyme lactase-phlorizin hydrolase (LPH) is found in 
humans. It is present mostly in the luminal side of the 
enterocytes of the small intestine. LPH hydrolyses lactose 
to glucose and galactose. It has also been reported 
that LPH can hydrolyse flavonoid-O-β-D-glycosides; this 
process causes a decreased polarity in the resulting 
aglycones, which can increase flavonoids cellular 
absorption36,37. Nevertheless, the activity of LPH can be 
inhibited by stearic factors and it may not hydrolyse 
glycosides like rhamnosides29.
Oxidation: Oxidative reactions are the most important of 
the phase I biotransformations of phenolic compounds. 
These reactions are mainly mediated by the enzymatic 
oxidative system regulated by microsomal cytochrome 
P-450 (CYP450). Human CYP450 is an enzyme with a 
broad spectrum of substrates. CYP3A4, a subfamily 
enzyme of CYP450 is involved in the metabolism of 
xenobiotics in gut. It has been reported that CYP3A4 
interacts with dietary phenolic compounds. This suggests 
that coadministration of drugs and phenolic compounds 
may stimulate some toxicity consequences38.
The metabolic action of CYP450 on phenolic compounds 
depends largely on their functional groups, molecular 
weight, stereostructure, glycosylation, polymerization, 
and conjugation with other phenolic compounds38,39. 
Moreover, flavonoids rich in hydroxylic groups are less 
likely to be metabolized by CYP450; paradoxically, 
tea catechins (flavonoids rich in hydroxyl groups) are 
reported to inhibit CYP45040.
Phenolic compounds metabolism is still under-studied. 
However, the potential health benefits of phenols urges 
more studies on the subject.
Phase II: Metabolism of Dietary Phenolic Compounds
Phase II biotransformation reactions include the addition 
of various chemical radicals to xenobiotic compounds. The 
transferred radicals are derived from endogenous, polar 
and high availability molecules in the body. The ultimate 
purpose of this process is to increase the polarity of the 
xenobiotic molecules. This increased polarity facilitates 
the excretion of xenobiotics through urine27,30.
The enzymes involved in phase II metabolism of 
dietary polyphenols are uridine 5’-diphospho-
glucuronosyltransferase, sulfotransferases and catechol 
O-methyltransferase. The resultant molecules are 
conjugated with sulfate, glucuronide and/or methylation 
groups27,30.
Phenolic-conjugated compounds differ from the parental 
molecule in size, polarity and ionic form. Therefore, 
the physiological behaviour of conjugated molecules is 
different from the native compound. Hence, there is an 
increasing need in knowing the possible contribution on 
health of these compounds. One way to achieve this is 
using phenolic-conjugated compounds in in vitro studies30.
Glucuronidation: The process of glucuronidation is the 
main conjugation reaction in humans. Glucuronidation 
incorporates to xenobiotic compound the glucuronic acid 
molecule through uridine diphosphate glucuronic acid 
(UDPGA) as substrate. The reaction may also use UDP-
glucose, UDP-xylose and UDP-galactose as a substrate27. 
The enzyme responsible for catalysing glucuronidation 
process is UDP-glucuronosyltransferase. This enzyme 
is found in the microsomal fraction of tissues as liver, 
kidney, skin, brain and small intestine41.
The site of glucuronidation is an electron rich 
nucleophilic heteroatom O, N or S. Therefore, the 
substrates for glucuronidation contain functional groups 
such as aliphatic alcohols and phenols (forming ethers 
O-glucuronide)42. Therefore, glucuronidation is one of 
the main conjugation reactions of phenolic compounds 
metabolism in humans43. 
Steffen et al. (2008)44 reported that glucuronide 
metabolites of (–)-epicatechin bind to a lesser degree 
to serum albumin than their aglycone counterpart 
does. Therefore, this can increase their absorption in 
enterocytes through β-glucuronidase or LPH activity. 
Moreover, aglycones lipophilicity is higher than 
flavonoids glycosides, therefore they can be more readily 
absorbed. Additionally, it would be interesting to study 
glucuronidation of phenolic acids and its effect on their 
bioaccessibility and bioactivity44.
Acetylation and Methylation: The acylated flavonoids 
such as epicatechin and epicatechin gallate are absorbed 
without prior hydrolysis or deconjugation11. Studies 
have shown that approximately 50% of the amount of 
(–)-epicatechin that reaches the intestinal cells are 
absorbed with a percentage of metabolites (especially 
sulfate conjugates) eliminated by efflux into the intestinal 
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lumen, and there exist a relatively modest elimination 
of (–)-epicatechin by bile, also have been observed a 
potential absorption of (–)-epicatechin and elimination 
by efflux in another segment of the gut lumen45.
Methylation differs from other conjugation reactions 
because it generally decreases hidrosolubility of phenolic 
compounds, also it masks functional groups that may be 
targeted by other conjugating enzymes27. 
As previously stated, flavonoids are mainly 
glucuronidated, nevertheless, methylated metabolites 
have also been detected, for example, perfusion studies 
with catechin or epicatechin have found O-methylated 
and glucuronidated forms. This process is thought to be 
mediated by catechol O-methyltransferase (COMT)46,47.
The O-methylation of flavonoids is a natural xenobiotic 
transformation by the O-methyl transferases, they are 
high selective enzymatic systems in plants, microbes 
and mammalians48. Methylation of phenolic compounds 
significantly increases their ability to be transported 
across biological membranes, making them more stable to 
metabolic changes; this can also increase their biological 
efficacy, particularly its antitumor activity in cell culture 
studies. In this sense, O-methylated flavonoids exhibited 
a superior anticancer activity than the corresponding 
hydroxylated derivatives in cell culture studies, being 
more resistant to the hepatic metabolism and showing 
a higher intestinal absorption49. Moreover, methylated 
flavonoids showed effects on transport proteins which 
play a central role in the defense of organism against 
toxic compounds (multidrug resistance proteins)50. 
It has been suggested that increasing the degree of 
methylation and decreasing the number of free hydroxyl 
groups that are available for conjugation with glucuronic 
acid and sulfate groups, stability and ability to transport 
across biological membranes is increased51.
 
CONCLUSIONS
Several epidemiological studies relate a decreased rate 
of chronic diseases in population with high intake of 
fruits, vegetables and cereals. Phenolic compounds are a 
group of antioxidant phytochemicals that are present in 
those plant-based foods; a large number of studies relate 
health promoting effects of plant-based foods to phenolic 
compounds. Nevertheless, there is a lack of knowledge on 
the metabolism of these compounds; these have led to a 
poor understanding of phenols mechanism of action. There 
is a need to go further into this kind of research in order to 
create better strategies to take advantage of phenols heatlh 
promoting properties.
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